In commercial plans and employer groups, adoption is accelerating: a 2025 Health Affairs/KFF survey found that 43% of firms with 5,000+ employees now cover GLP-1s for weight loss, up from 28% in 2024 ( [26] ), and 57% of employers overall cover GLP-1s for weight loss according to WTW survey data ( [27] )
Forging the Path Meet the Team Our vertically integrated team includes in-house corporate credit advisory, construction administration, asset management, accounting and capital markets
So, this cascade disabled the cell capacity to convert toxic lipid hydroperoxides (L-OOH), such as malondialdehyde (MDA) and 4-hydroxy-trans-2-nonenal, into less-toxic lipid alcohols (L-OH) and culminated in cell death from lipid peroxidation
For semaglutide, the SmPC advises a washout period of approximately two months before planned conception
3.6 PheWas To thoroughly assess whether the identified potential drug target gene TOR1B might exert beneficial or detrimental effects on other traits, and to explore potential pleiotropy not captured by the MR-Egger intercept test, we utilized 17,361 binary phenotypes and 1,419 quantitative phenotypes from the AstraZeneca PheWAS portal
